InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Tiny Gems
Thursday Oct 26, 2023 - 12:00 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Selected by Leading Pharmaceutical Giant for Vital Logistics Operation

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning and providing a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today announced a significant achievement with the recent success of securing an RFQ (Request for Quotation) from a leading global pharmaceutical giant. According to the…

Continue Reading

Wednesday Oct 25, 2023 - 10:01 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, has entered into a definitive agreement for the issue and sale of more than 3 million common shares, or prefunded warrants in lieu thereof. Specifically, the company agreed to a private placement of 3,012,049 common shares priced at $0.83 per share. In addition, the company…

Continue Reading

Tuesday Oct 24, 2023 - 10:41 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced its selection of a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s treatment model. InMed will be advancing cannabinoid analog INM-901 in its pharmaceutical drug development program. “The most recent studies of INM-901…

Continue Reading

Monday Oct 23, 2023 - 10:17 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Update on Progress of Action Filed Against Key Broker Dealers

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on the status of the lawsuit it filed against TD Ameritrade, Charles Schwab, National Finance Services and others alleging that those broker dealers engaged in a scheme to manipulate the share price of the company’s securities. Mullen filed the lawsuit in August 2023 in the United States District Court in the Southern District…

Continue Reading

Friday Oct 20, 2023 - 3:29 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Committed to R&D, Eyeing Excellent Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator seeking to enhance the bioavailability of multiple active pharmaceutical ingredients using its patented DehydraTECH(TM) drug delivery technology platform. The company continues to devote an increasing proportion of its resources and focus toward research and development (“R&D”) as part of its overall goal to establish areas of investigation for commercial pursuits and reduce risks of the unknown…

Continue Reading

Friday Oct 20, 2023 - 2:53 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Drive Toward Potential New GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced rapid enrollment in its potentially pivotal study involving its flagship drug candidate, Berubicin, and is moving closer to reporting the results of its drive toward a new treatment for the effectively incurable brain cancer glioblastoma (“GBM”). “The Texas-based company has clinical trial sites operating in the U.S., Italy, France, Spain, and Switzerland, to evaluate Berubicin’s performance against standard of…

Continue Reading

Thursday Oct 19, 2023 - 1:38 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Ask the CEO Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured at this month’s Virtual Investor Ask the CEO Conference. CNS Pharmaceuticals CEO John Climaco is scheduled to participate in a live moderated webcast during the conference; the webcast is slated to start at 4 p.m. ET.…

Continue Reading

Thursday Oct 19, 2023 - 11:55 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Schedules Q3 Earnings Release, Conference Call Date

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is planning to release its third-quarter 2023 financial results on Nov. 9, 2023; the report will be released following market close. Cepton has also scheduled a conference call and webcast for that same day; the call will begin 5:30 p.m. ET. During the call, management will discuss the quarter earnings report as well…

Continue Reading

Thursday Oct 19, 2023 - 11:03 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Filing of Preliminary Proxy Statement

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission (the “SEC”) regarding a special stockholders’ meeting to be held on Dec. 15, 2023, to authorize Mullen’s board of directors to effect a reverse stock split of the company’s common stock at an exchange ratio between 1-for-2 to 1-for-100.…

Continue Reading

Thursday Oct 19, 2023 - 10:00 am

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Featured in Bell2Bell Podcast

GEMXX (OTC: GEMZ), a mine-to-market enterprise specializing in gold, gemstone and jewelry production, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Richard Clowater, president of GEMXX, joined the program to share insight into the company, beginning the interview expounding on a recent news release detailing why management feels…

Continue Reading

Monday Oct 16, 2023 - 1:08 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Status of Commercial Vehicle Production

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a commercial vehicle production update for its Class 3 EV cab chassis trucks and Class 1 EV cargo vans. According to the report, the company is on track to produce 150 Class 3 EV trucks through December 2023 and to begin production and delivery of its Class 1 EV cargo van in Q4…

Continue Reading

Monday Oct 16, 2023 - 12:15 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Innovative Glioblastoma Treatment ‘Could Offer Hope’

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted in a recent article focused on glioblastoma, the most aggressive type of brain cancer. Noting that glioblastoma has an average survival of only 14 to 16 months after diagnosis, the article points out that currently, glioblastoma has no cure…

Continue Reading

Monday Oct 16, 2023 - 10:00 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds Smallest Machine Yet to Crime-Fighting Portfolio

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that its crime-fighting tech portfolio is expanding with the addition of the K1 Hemisphere. According to the announcement, the K1 is the company’s smallest machine to date. The new ASR carries the slogan: Half a World of Information at Your Fingertips.  The announcement noted that the…

Continue Reading

Friday Oct 13, 2023 - 11:56 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Inks Global Collaboration, License Agreement with SulfoSyn

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has granted a new global, exclusive license to SulfoSyn Limited; the license is for the exclusive global use of all nonpharmaceutical applications of Lexaria’s proprietary DehydraTECH-sulforaphane, including the right to authorize sublicenses. According to the announcement, Lexaria has already received an up-front cash payment, and the agreement outlines minimumongoing payments, royalties and manufacturing revenues.…

Continue Reading

Friday Oct 13, 2023 - 10:43 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds Two K5 ASR Contracts to Growing List of Clients

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is continuing to add to its list of valued clients. The company has secured two more contracts for its K5 ASR, including a hotel in Athens, Georgia, and a Pre-K school in Vancouver, Washington. According to the announcement, the hospitality market is recognizing the many advantages that Knightscope ASRs offer.…

Continue Reading

Thursday Oct 12, 2023 - 12:24 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs and K1B Emergency Communications Systems Deployed for New and Existing Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced two new sales for its K5 ASRs and an expansion sale from an existing user of its K1B line of emergency communication systems. The announcement reads, “Two Portland, Oregon, hotels each signed contracts for Knightscope ASRs to patrol their parking areas after the word-of-mouth-success of another Portland…

Continue Reading

Thursday Oct 12, 2023 - 12:15 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Portfolio Expansion to 37 Granted Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has been granted two new patents by the Canadian Intellectual Property Office (“CIPO”), increasing its portfolio to 37 granted patents. According to the update, Canadian Patent #2,984,917, “ Stable Ready-to-drink Beverage Compositions Comprising Lipophilic Active Agents, ” was granted on Sept. 26, 2023, and expires Dec. 1, 2036. The…

Continue Reading

Wednesday Oct 11, 2023 - 1:11 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Rapid Pace of Enrollment in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer; the company expects to ultimately enroll 243 in the study. Participants are being…

Continue Reading

Monday Oct 09, 2023 - 12:27 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Emergency Communication Systems Deployed for Four Existing Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced new purchase orders. The orders are from four existing customers – two cities and two universities – seeking to grow and improve their emergency communications systems. The announcement reads, “Advocates, individuals and government officials at all levels must do everything they can to ensure that schools are…

Continue Reading

Monday Oct 09, 2023 - 11:26 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Marianne McInerney as Chief Strategy Officer

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the appointment of Marianne McInerney as chief strategy officer. According to the announcement, McInerney will focus on growth opportunities and drive strategic initiatives for Mullen’s commercial, consumer vehicles and governmental affairs. McInerney has nearly two decades of experience in the automotive and transportation industry, during which she has advised multiple original equipment manufacturers,…

Continue Reading

Wednesday Oct 04, 2023 - 2:36 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASR, K1 Hemisphere for New Contracts in Southern California

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced two new contracts from a Los Angeles area shopping center and a medical clinic. The announcement reads, “The Knightscope K5 Autonomous Security Robot (‘ASR’) will be patrolling the interior of a large, cultural mall in the Los Angeles area. Shopping centers are places where people go to…

Continue Reading

Tuesday Oct 03, 2023 - 3:04 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Emergency Communication Systems to Bolster Public Safety Programs in Healthcare and Education

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced three new sales for its K1B Emergency Communications Systems. According to the update, the orders were placed by a college in Pennsylvania and two hospital systems – one in Illinois and one in Indiana. The announcement reads, “Healthcare organizations across the U.S. have partnered with Knightscope for…

Continue Reading

Tuesday Oct 03, 2023 - 11:09 am

InvestorNewsBreaks – GEMXX Corporation (GEMZ) Announces Partnership with Aurora Geosciences to Confirm Resources, Increase Asset Value

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a 50% partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), is partnering with Aurora Geosciences to complete S-K 1300 technical reports on four assets. According to the announcement, two of GEMXX’s gold reserves along with two of its largest ammolite gemstone claims have not yet confirmed by an engineer report. Because…

Continue Reading

Monday Oct 02, 2023 - 2:39 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Nicotine Pouch Demonstrates Advantages over Competition

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently reported results from its human oral nicotine study NIC-H22-1, comparing Lexaria’s DehydraTECH(TM)-nicotine tobacco-free pouch to world-leading brands ZYN(R) and on! “Using measurements to determine the median time required to reach comparable nicotine concentrations within the bloodstream (‘Tmax’), Lexaria exhibited higher levels of certain pleasurable effects over the competition. DehydraTECH also provided the…

Continue Reading

Monday Oct 02, 2023 - 9:59 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces CEO to Participate at Emerging Growth Conference

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, will be participating at this month’s Emerging Growth Conference. The event is slated for Oct. 4–5, 2023. Knightscope CEO and chair William Santana Li is a featured presenter on the agenda. According to the announcement, Santana will be presenting a fireside chat titled “AI Robots.” During his presentation,…

Continue Reading

Friday Sep 29, 2023 - 12:51 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Upcoming $1.6M Registered Direct Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into a securities purchase agreement with a single healthcare-focused institutional investor; the agreement is for the purchase of 1,618,330 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering. According to the announcement, Lexaria also agreed to issue and sell warrants to purchase up to 1,618,330 shares…

Continue Reading

Thursday Sep 28, 2023 - 11:14 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Class 3 EVs Begin Shipping

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has delivered the first 10 class 3 EV Cab Chassis Truck to Randy Marion Automotive Group; the vehicles are invoiced at $630,000. According to the announcement, these first 10 vehicles are the initial shipment of an order for 1,000 class 3 vehicles, an order worth $63 million; the order was placed in May 2023. The…

Continue Reading

Wednesday Sep 27, 2023 - 1:56 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Issues Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared an open letter to shareholders from its CEO David Michery. In the letter, Michery discusses updates on various matters, company milestones and initiatives, including the company’s strong balance sheet, its receipt of EPA certification for Class 3 EV commercial vehicles, status on the hearing granted before the Nasdaq Hearings Panel, its firm stance…

Continue Reading

Wednesday Sep 27, 2023 - 10:00 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Update to Fr8App Platform: Integration with Geotab’s Open API

Freight Technologies (NASDAQ: FRGT), a technology company, has released an improvement to its innovative custom developed app: Fr8App. An industry-leading, freight-matching platform powered by artificial intelligence (“AI”) and machine-learning, Fr8App offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. With the recent enhancement, Fr8App now integrates with Geotab’s open application programming interface (“API”). This new feature provides shippers and…

Continue Reading

Tuesday Sep 26, 2023 - 10:27 am

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Enters Binding LOI to Acquire 50% Interest in Proven Yukon Gold Project

GEMXX (OTC: GEMZ), an enterprise specializing in gold, gemstone and jewelry production, today announced its entry into a binding letter of intent (“LOI”) to acquire an initial 50% stake in The Yukon Gold Project (“the property”), pending conclusion of due diligence and verification of the considerable exploration work already completed on the property and the assessments quantifying the proven and potential gold resources. According to…

Continue Reading

Tuesday Sep 26, 2023 - 10:04 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Technology Services to Expand Deployment Across PENN Entertainment Portfolio

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced its entry into an agreement with PENN Entertainment, Inc. Under the agreement, Knightscope will offer its technologies to PENN Entertainment’s 43 nationwide gaming and racing properties. Knightscope recently deployed its first K5 ASR at Penn Entertainment’s M Resort Spa Casino in Nevada, followed with subsequent deployments at…

Continue Reading

Tuesday Sep 26, 2023 - 9:33 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Commercial Class 3 EV EPA Certification

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reached a key milestone. The company announced that it has received full approval from the Environmental Protection Agency (“EPA”) with certification for class 3 EV commercial vehicles; the company received the notification on Sept. 22, 2023. According to the announcement, the company has also completed all testing requirements for its class 3 EV Cab…

Continue Reading

Monday Sep 25, 2023 - 9:16 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 Security Robot Deployed in NYPD Pilot Program

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that the city of New York and the New York Police Department (“NYPD”) launched the Knightscope K5 security robot service. The move was announced at a press conference with the support of the Metropolitan Transportation Authority (“MTA”). The first two weeks will be spent on training, configuration…

Continue Reading

Friday Sep 22, 2023 - 1:59 pm

InvestorNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)

RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force. “UPNEEQ(R) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis… UPNEEQ(R), the first and only FDA-approved eye drop for low-lying eyelids, fits into the non-invasive medical…

Continue Reading

Friday Sep 22, 2023 - 11:15 am

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Featured in Bell2Bell Podcast

GEMXX (OTC: GEMZ), an enterprise specializing in gold, gemstone and jewelry production, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Richard Clowater, president of GEMXX, joined the program and IBN’s Stuart Smith to provide an introduction of ammolite, an extremely rare gemstone, and discuss the company’s innovative business…

Continue Reading

Friday Sep 22, 2023 - 9:46 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) CCO Talks Industrializing Lidar with Automotive Programs, Company’s Reverse Stock Split Takes Effect

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton’s new chief commercial officer Mitch Hourtienne was a guest during a recent Proactive Investors interview. During the interview, Hourtienne, who has been serving as Cepton senior vice president, and Proactive Investors host Steve Darling discussed his 20-year-plus journey to Cepton as well as his new responsibilities. Hourtienne has…

Continue Reading

Thursday Sep 21, 2023 - 1:55 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces New Studies to Examine DehydraTECH(TM)-Powered GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its intention to launch new human and animal studies to examine DehydraTECH(TM)-processed glucagon-like peptide-1 (“GLP-1”) drugs such as, but not limited to, semaglutide sold under Novo Nordisk’s brand names Ozempic(R), Wegovy(R) and Rybelsus(R), for purposes of improved  bioavailability, cost-effectiveness, tolerability, weight loss potential, management of diabetes and other health conditions. According…

Continue Reading

Thursday Sep 21, 2023 - 11:12 am

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Cargo Vans Purchased by NYPA on Heels of Successful EV Pilot

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the New York Power Authority (“NYPA”) has purchased the company’s campus delivery cargo vans after successful completion of an EV pilot program at NYPA’s 16-turbine hydroelectric facility in northern New York. According to the update, the 60-day EV cargo van pilot began on July  6, 2023, and concluded in early September 2023.…

Continue Reading

Wednesday Sep 20, 2023 - 12:12 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces 100th Landing of Its Robot Show

Knightscope (NASDAQ: KSCP) is a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems. The company has announced its 100th Robot Roadshow landing that will take place on Oct. 3, 2023, at Rich Township High School in Richton Park, Illinois. The announcement reads, “Knightscope’s Robot Roadshow (‘Roadshow’) was developed and launched during the pandemic, which brought all tradeshows and related gatherings…

Continue Reading

Wednesday Sep 20, 2023 - 11:54 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Building Protection and Powerful IP Portfolio for Its Diabetes Gene Therapy Program

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, recently announced its entry into an exclusive license agreement related to a particular gene therapy for both type 1 and type 2 diabetes. “Specifically, the announcement involves a worldwide exclusive license to a patent application and related technology, and a worldwide non-exclusive license to use certain…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).